Medipharm Labs Corp (LABS : TSX)
Common Stock
Follow LABS
LABS
Medipharm Labs Corp
Performance
1 Day
+0.00%
1 Week
+8.33%
1 Month
+0.00%
YTD
-7.14%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$27.77M
52W High
$0.10
52W Low
$0.06
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.84
Dividend Yield
-
Performance history
LABS returns since 2023
Medipharm Labs Corp has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −47.8% (Mar 2025 to Nov 2025).
1 year / yr
−7.1%
3 years / yr
0.0%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−7.1%
- 2024−7.7%
- 2025+8.3%
- 2026*0.0%
* Partial year (first year of data, or year to date).
$10,000 invested in LABS
- 1 year ago$9,286
- 2023 (start of our data)$9,286
- Best year
- 2025: +8.3%
- Worst year
- 2024: −7.7%
- All-time high in our data
- $0 on Mar 24, 2025 · now −43.5%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
LABS earnings history
Medipharm Labs Corp beat the EPS estimate in 0 of its last 2 reported quarters.
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | $0.00 | — | — |
| Mar 31, 2026 | May 13, 2026 | −$0.00 | $0.00 | — |
| Dec 31, 2025 | Mar 30, 2026 | −$0.00 | $0.00 | — |
| Sep 30, 2025 | Nov 13, 2025 | −$0.01 | — | — |
| Jun 30, 2025 | Aug 14, 2025 | −$0.01 | — | — |
| Mar 31, 2025 | May 14, 2025 | −$0.00 | — | — |
| Dec 31, 2024 | Mar 31, 2025 | −$0.01 | — | — |
| Sep 30, 2024 | Nov 14, 2024 | −$0.01 | — | — |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past LABS? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 16,735 |
| 11/13/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 115,659 |
| 11/12/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 238,344 |
| 11/11/2026 | $0.07 | $0.07 | $0.06 | $0.07 | $0.07 | 715,784 |
| 11/10/2026 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | 69,490 |
| 11/9/2026 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | 290,446 |
| 11/6/2026 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | 80,370 |
| 11/5/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 350,743 |
| 11/4/2026 | $0.07 | $0.07 | $0.06 | $0.07 | $0.07 | 64,831 |
| 11/3/2026 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | 7,128 |
Analyst Price Targets
Based on analyst covering LABS · as of Sep 17, 2026
Wall Street analysts forecast LABS stock price to rise 53.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.10
+53.8% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LABS's historical volatility
30-Day Vol
93.4%
Annualized
90-Day Vol
79.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.08 |
| 60 trading days | C$0.06 | C$0.04 – C$0.09 |
| 90 trading days | C$0.05 | C$0.03 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medipharm Labs Corp
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
Financials
- Revenue (TTM)
- $41.46M
- EBITDA
- $-2.41M
- Profit Margin
- -12.00%
- ROE (TTM)
- -13.22%
- EPS (Diluted)
- -0.01
- Book Value
- 0.08
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About LABS
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Free with a Wealth Awesome account
Keep analysing LABS, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.